Understanding the dynamical evolution of cancer, with the final goal of developing effective techniques for diagnosis, prediction and treatment is one of the main challenges of modern biosciences. In this paper we approach the temporal ordering reconstruction problem, which refers to the temporal sorting of a collection of static biological data. The solution of this problem may help in better understanding the key principles and properties of the disease progression. By using a previously proposed technique for extracting temporal progressions from cross-sectional cancer gene expression data, we develop a novel methodology to be applied to static cross-sectional copy number alterations, and we test it on patients diagnosed colorectal cancer at different stages. To capture distinct aspects of this complex phenomenon, we define several measures of chromosomal alterations and filters targeting significant portions of chromosomes. Results obtained with various measures and filters highlight the best setting for the problem, the most relevant chromosomal alterations and emphasize the influence that copy number alterations hitting key genes may have on the development of the disease.
Introduction
Cancer is a complex disease caused by different factors and events, mostly affecting the dynamics of the gene regulatory networks and of the signaling pathways that normally rule the correct functioning of cells, tissues and organs. As such, understanding and characterizing cancer dynamics and development is one of the big challenges of modern biosciences, in conjunction with the development of suitable and effective techniques for diagnosis, prediction and treatment. To this end, the collection and the in-depth analysis of experimental biological data is fundamental in order to validate theories and models, both from the qualitative and the quantitative point of view, and to foster the formulation of new hypotheses and experimental directions.
Yet, even though the amount of cancer-related data publicly available in the various databases is nowadays huge [The Cancer Genome Atlas Network (2016) ], the challenge is now to deal with the dynamical characterization of such a complex phenomenon. Therefore, extracting useful information about cancer progression (i.e., a form of "dynamical" information) from "static" biological data would have a major significance and impact on the related research.
This paper approaches the "temporal ordering reconstruction problem" (tor), that is the sorting of a collection of multi-dimensional biological data to reflect an accurate temporal progression of the target disease. Despite being a general statement problem, we restrict it to considering Copy Number Alteration (CNA) data from a set of patients at different stages of the disease and, in particular, we focus on the case of colorectal cancer progression. There are few studies that approach various forms of the tor problem using various types of data but, to the best of our knowledge, CNA data has not been used to solve the tor problem as defined above, i.e., to reconstruct the temporal ordering of a given set of samples [Desper et al. (1999) , Pathare et al. (2009) ].
Colorectal cancer. Colorectal cancer (CRC) is the third most common type of cancer worldwide and the second most frequent cause of cancer-related death [Jemal et al. (2010) ]. Most CRCs develop through a series of distinct morphological stages that are strongly correlated with the malfunctioning of the complex signaling networks ruling the intestinal crypt dynamics and homeostasis, which is induced by the accumulation of alterations in the function of key regulatory genes and genetic instability [Vogelstein et al. (1988) , Fearon & Volgestein (1990) , Kinzler & Vogelstein (2002) , Frank (2007) , Jass (2007) , Medema & Vermulen (2011) , The Cancer Genome Atlas Network (2012) ]. In particular, three major forms of genetic instability in CRC have been described: microsatellite instability, epigenetic changes, e.g. DNA methylation, and chromosomal instability. These happen in 13 %, 40 % and 47 % of the cases, respectively [Ashktorab et al. (2010) ]. Chromosomal instability is associated with a poorer prognosis than that in patients with microsatellite instability [Walther et al. (2009) ]. The chromosomal instability usually implies gains and losses of segments of chromosomes.
In the "standard progression", which covers around the 60% of the cases, the disease progression crosses a few major phenotypic stages, i.e., adenoma, carcinoma and metastasis, through a number of intermediated phases and minor events. The samples and data that we have analyzed so far were classified by pathologists, using histological analysis, according with the standard four stages classification for CRC: the first one being the least severe and the fourth implying cancer metastasis [Reid et al. (2009) ].
Copy number alterations. Chromosomal CNAs refer to regions of the DNA that have either been deleted or duplicated a certain number of times on chromosomes. These aberrations may affect the function of certain genes, modifying their expression and have been associated with susceptibility or resistance to certain diseases. In cancer, chromosomal CNAs can also lead to activation of oncogenes and inactivation of tumor suppressor genes. Mutation or deletion, generally of both copies, leads to inactivation of tumor suppressor genes, while oncogenes become active through mutation or amplification, usually of one copy [Sheffer et al. (2009)] . These CNAs can be as large as numerical anomalies of entire chromosomes, or as small as segmental amplification or deletion of less than 10 kb. Although a preferred order for the genetic alterations in CRC progression exists, the total accumulation of CNAs rather than their order is likely most important [Fearon & Vogelstein (1990) ]. A comprehensive picture of chromosomal gains and losses during the progression from high-grade adenomas to invasive carcinomas is found in CRC tumors [Ried et al. (1996) , The Cancer Genome Atlas Network (2012)]. One class of genetic alterations involves mutations of oncogenes and tumor-suppressor genes that directly control cell birth and death, such as APC, KRAS, and p53 [Shen et al. (2007) ]. The chromosome 7 amplification, which is also observed in some colon adenomas, occurs at early stages of colorectal tumor progression [Bomme et al. (1994) ]. During the progression from high-grade adenomas to invasive carcinomas, other specific chromosomal aberrations become common, such as gains on 8q, 20q, 7, 13 and deletions on 8p, 17p,18q,15q and 20q [Ashktorab et al. (2010) ].
State of the art. The tor problem is general and can be approached from different, often complementary, perspectives. The Machine Learning and Data Mining communities pose the general problem as "parallel" to the standard classification one; some studies have shown that the general problem is NPcomplete [Cohen et al. (1999) , Ramakrishnan et al. (2009)] .
In Computational Biology and in Bioinformatics we can distinguish at least two complementary lines of work. On one side, the tor problem is framed as the task of re-ordering, according to some "logic", a set of independent quantitative "observations" of a phenomenon. This version of the tor problem was mostly studied with cross-sectional gene expression data as input [Magwene et al. (2003) , Gupta & Bar-Joseph (2008) , Czibula et al. (2013) , Guo et al. (2014) ]. On the other side, the tor problem can be framed as the problem of inferring causal relations among the "observables" associated to the input obser-vations. This version of the problem was mainly studied within cancer research. In this case CNA data extracted via, e.g., Comparative Genomic Hybridization, is analyzed to understand which CNA is functional to cause other CNAs. The mathematical techniques used to solve this problem span from tree-based inference to Bayesian networks, and the driving logic relies on the accumulation of CNAs in a progressing cancer [Desper et al. (1999) , Pathare et al. (2009 ), Gerstung et al. (2011 ), Beerenwinkel et al. (2005 , Olde Loohuis et al. (2014), Ramazzotti et al. (2015) ].
Clearly, these two aspects of the tor problem are complementary: the former sorts the input observations, i.e. the samples, according to their profiles of CNA alterations, while the latter defines causal models involving the events associated to the input observations, i.e. the CNA alterations themselves. Both versions of the tor problem are interesting, and their solutions can be used to yield, together, a better comprehension of cancer in the form of, e.g., a CNAlevel classifier for profiles/accumulations.
In this preliminary work, we focus on the first of the two interpretations of the tor problem, extending to CNAs the work on expression data by Gupta and Bar-Joseph [Gupta & Bar-Joseph (2008) ]. Albeit conceptually simple, the technique is effective and promising, and is based on the reduction of the sorting problem to a well-known route-planning problem, under two biologically reasonable assumptions over the data. We shall use this technique looking solely to CNAs, rather than gene expression; in the next sections we will recall the intuitions underlying this approach.
A different approach based on minimum spanning trees and PQ-trees is introduced by Magwene et al. [Magwene et al. (2003) ]. The minimum spanning tree algorithm is applied on a weighted, undirected graph, in which nodes are represented by multi-dimensional microarray data. These algorithms are tested on artificial data sets, as well as on time-series gene expression data sets derived from DNA microarray experiments.
Goals. Our work leverages the work of Gupta and Bar-Joseph, applied to CNA data. In our analysis, we also provide a more fine grained look on the events that may characterize a change in the progression profile; as it will become clear in the paper, we look at a "segmentation" of the SNP data and not only at chromosomal arms gains and losses [Daruwala et al. (2004) ]. Finally, one more goal we pursue is to provide a building block in an analysis pipeline that can be used to look at temporal reconstruction problems that assume an already (partially) ordered dataset [Ramakrishnan et al. (2010) , Antoniotti et al. (2010) ]. A preliminary version of this work was presented as a poster at NETTAB 2012, Workshop on 'Integrated Bio-Search' [Bocicor et al. (2012) ].
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2 The Gupta and Bar-Joseph method for static expression data
Gupta and Bar-Joseph [Gupta & Bar-Joseph (2008) ] formally show that, under a model of a single gene dynamics, the correct ordering of the static expression data sets can be recovered by solving an instance of the Traveling Salesman Problem (TSP).
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The approach by Gupta and Bar-Joseph is based on two key hypotheses:
(i) a gene driving a specific disease does not change the direction of its expression trajectory very often (i.e., its expression level either increases or decreases);
(ii) at any time point, a gene will remain at the same expression level as the previous time point with some probability.
Statement (i) means that a gene going up at a specific time point is likely to go up or remain at the same level in the next time point. Thus, despite the fact that a gene may change its expression trajectory directions multiple times, if enough data is available then the probability of this event is
where p is the probability that a gene will not change its direction between two successive time points. This assumption is supported by some data sets where very few genes change directions more than once, i.e. most genes responding to the condition either go up and then down, or vice versa [Gasch et al. (2000) , Nau et al. (2002) ]. Statement (ii), which subsumes a Markov interpretation of the process, is formalized stating that a gene increases or decreases its expression level, depending on its direction, with some probability 1 − q, thus it does not change with probability q. In general, q should be small indicating that most genes do not change in time.
Setting on these premises, the random variable
is defined where Z i (t) is the expression of the i-th gene at time t [Gupta & Bar-Joseph (2008) ]. This variable models the expression of the set of genes one wants to consider, m in this case, assumed to be independent. A one-step theorem is then proved stating that, for all possible time steps t = 1, . . . , T , the inequality
holds with probability at least 1 − T e −O(m(1−q)) . Here, the L 1 metric || · · · || 1 is used, i.e.
n . Conditions for this inequality to hold are reasonable: q < 1, i.e., a gene has time-varying expression, and for p ∈ (1/2, 1], i.e., a gene is more likely to maintain its expression direction in two consecutive steps. Under the very same assumptions, this one-step theorem generalizes to
which holds with probability at least 1 − T 2 e −O(m(1−q)) , for k ≥ 2. The reduction to the TSP problem proposed by Gupta and Bar-Joseph is as follows (see the Appendix for details): a graph G = (N, E) is built where the set of nodes N = {p i | i = 1, . . . , n} is composed by all the n gene expression profiles input to the tor problem, i.e. the profiles p i we want to order. The graph is strongly connected, i.e. any profile can precede any other in the tor solution, and the entry p i,j of the matrix Π of distances is
for i, j = 1, . . . , n. When n log T the unique TSP path reconstructs the correct ordering with high probability.
The method was applied to 50 patients affected by glioma, showing a good correlation with the survival times. By the tor solution an outperforming classifier was also defined and key oncogenes identified [Gupta & Bar-Joseph (2008) ].
Methods
To use the Gupta-Bar-Joseph method on CNA, rather than expression data, we must be sure that such data fulfill the hypotheses recalled in the previous section [Gupta & Bar-Joseph (2008) ]. This is indeed the case, as outlined in some studies [Staub et al. (2006) , Habermann et al. (2007) , Sheffer et al. (2009) , The Cancer Genome Atlas Network (2012)]. Among others, Tsafrir et al. showed that changes in expression level of genes are correlated to CNAs, suggesting that particular chromosomal regions are frequently gained and overexpressed (e.g., 7p, 8q, 13q, and 20q) or lost and underexpressed (e.g., 1p, 4, 5q, 8p, 14q, 15q, and 18) in primary colon tumors [Tsafrir et al. (2006) ]. They also showed that these aberrations are absent in normal colon mucosa and become more frequent as the disease advances. Reid et al. combining gene expression and CNA data, identified more precise selected aberrations altering the expression of multiple genes involved in CRC development [Reid et al. (2009)] . Therefore, it is safe to assume that CNAs: (i) span over genes that are important for CRC development;
(ii) do not significantly change the alteration direction (i.e. gain/loss) very often;
(iii) are not likely to significantly change between two successive time points.
Thus, we are assuming the same hypotheses by Gupta and Bar-Joseph, rephrased in the context of CNAs, and their approach to solve the TOR problem can then be used in this context as well. We remark that the application of the technique here discussed to other types of genomic data regarding, e.g., somatic mutations or epigenetic phenomena (e.g., DNA methylation) could be sound, provided that the two key hypotheses discussed in Sect. 2 are verified. However, the verification of these hypotheses in different contexts is not straightforward. An in-depth discussion on how proceeding to set up such context-dependent verification is a very interesting problem per se and we will pursue it in a future work as we further develop the underlying theory.
Measuring chromosomal alterations
is (a measure of) the CNAs associated to the i-th chromosome 2 . Set S = {S k | k = 1, . . . , n} is our data set with n samples. Each value v i is a measure capturing different aspects of CNAs; testing several measures allows to understand which one performs best with respect to CRC progression, as done in other studies concerning genetic instability [Paris et al. (2004) , Herzog et al. (2006) ].
Blaveri et al. used the fraction of genome altered, the number of whole chromosome changes, the number of copy number transitions within a chromosome, the total number of chromosomes containing transitions, amplifications, and deletions [Blaveri et al. (2005) ]. The authors found that early-stage bladder tumors differed significantly from late-stage tumors with respect to these measures. Peng et al. have not found significant difference in the average number of loci with CNAs between early and late stage gastric carcinoma, while amplifications were more common in advanced cancers than in early ones [Peng et al. (2003) ].
Thus, given this uncertainty, we decided to test measures which consider separately deletions or amplifications, measures accounting for the actual values of the alterations, or for the number of alterations. For chromosome k, our input data is a multiset C k = {x i ∈ N}. We term value of an alteration any of the x i 's, and we term intensity of an alteration its distance from the expected value 2, i.e., |x i − 2|, accounting that two copies of a certain segment of DNA are expected to be present. Given C k we defined the measures in top of Table 1 by aggregating deletions and amplifications. Intuitively, IA k weights how much a CNA is amplified, VA k gives greater weight to the actual CNA value while NA k simply counts the number of CNAs. The measures with the avg superscript are simply the averaged analogous. For a set C 5 = {3, 4, 3, 3, 3, 1} we have IA 5 = 7, VA k = 17 and NA k = 6, so IA avg k = 7/6 and VA avg k = 17/6. We also considered measures separating amplifications from deletions, as done in previous studies [Herzog et al. (2006) , Paris et al. (2004)] . A deletion happens when the CNA value is x i < 2, an amplification when x i > 2; thus we
Measures aggregating deletions and amplifications (C
These two sets yield the measures in the mid and bottom panels of Table 1 , which have the usual meaning.
Filtering the input data: recurrent and cancer-specific genes
So far we processed any input x i , representing some alteration, without considering its absolute frequency in the data set S, or any a priori biological knowledge. However, it could be that certain filters applied on S could lead us towards obtaining more accurate orderings. In particular, it is legitimate to argue that (i) the most recurrent alterations and (ii) alterations in genome regions encoding cancer-specific genes could be privileged to infer progression. To define both (i) and (ii) we use information on the chromosomal regions containing CNAs. Let I xi be the interval to which alteration x i maps to, and let no(I xi , S) be the number of occurrences of I xi in data set S. Notice that
Figure 1: Input data. Euler diagram representing the nine different input sets and the relationships among them. C k refers to CNAs for a specific chromosome k, D k and A k respectively refer to deletions and amplifications for chromosome k as well. Superscript indexes rec and cdg respectively refer to recurrent CNAs and cancer driver gene-related CNAs. We remark that C two alterations could belong to two (or more) partially overlapped intervals. As no(I xi , S) increases that the DNA in I xi contains CNAs in a larger number of samples. Thus, for (i) it suffices to restrict C k (or, analogously,
For (ii) we consider both recurrent CNAs and CNAs which belong to intervals of the DNA coding for the genes presented in Table 2 3 . So, if G is the set of all DNA intervals containing at least one cancer driver gene, then:
The chromosome measures defined in Table 1 can then be applied on these filtered data sets. The data sets we discussed are graphically represented in Figure 1 .
Results
This section presents a performance evaluation and a discussion of the results obtained by our technique. Tests were extensively performed on synthetic data, real applications on two groups of patients diagnosed with CRC. 
Synthetic data
We evaluated the performance of our algorithm on a large set of synthetic data with various size and affected by the presence of noise. Each data set is generated by the following procedure, which we shortly report here and discuss in detail in the Appendix. We hypothesize the existence of N disjoint life expectancy classes, and create M samples "naturally" clustered for each class. A sample is a vector in which every component represents the overall CNAs of a specific chromosome; its value is randomly assigned according to the values common to the sample class. The basic assumption that to a larger CNA magnitude corresponds lower survival as a consequence of the disease progression, is fulfilled by defining a total ordering among classes. We make this synthetic data more realistic by including a Binomial model of experimental error and intrinsic biological variability. This is obtained in the form of a noise parameter p ∈ [0, 1]. With probability p any CNA is assigned a random value, regardless of the class the sample belongs to (e.g., if p = 0.1 around the 10% CNAs in each sample are purely random). The goal of this analysis is to determine, as a function of p, the percentage of samples that are misclassified by the method.
In Figure 2 we display the average and best performance of the algorithm for different values of noise, number of chromosomes and number of samples for each class, with respect to the L 1 metric.
4 As expected, the method correctly orders the whole set of samples (error approx. 0, on average) when data is "clean" (i.e., p = 0), and dramatically drops in performance for p ≥ 0.3. All in all, this suggest that the method might fail when intense noise is expected, Figure 2 : Performance on synthetic data. Average/minimum error ratio for the reconstruction method. Noise is discretized and 100 synthetic data sets with 10 life expectancy classes containing 25, 50, and 100 distinct samples are created. Combinations of 15, 20 or 25 chromosomes are used. which hints at the intrinsic difficulty of inferring an effective ordering in the presence of noise.
Colorectal cancer -dataset 1
The first real life data set we used was taken from the study of Reid et al. [Reid et al. (2009)] . It contains tissue specimens from 53 consecutive sporadic CRCs, which we reduce to 44 since for 9 samples the stage of the tumor was unknown. The samples were hybridized to Affimetrix GeneChipVR Human Mapping 250K NspI (SNP arrays). Raw intensity CEL files of the SNP arrays were processed with CNAG program v.2.0 to detect chromosomal CNAs, using an unpaired reference of 44 HapMap normal samples [Nannya et al. (2005) , Reid et al. (2009)] . With this procedure we obtain a CNA value for each, per chromosome. The CNAs for the whole set of samples are illustrated in Figure  3 .
For each sample we are given a series of information, the most important being the overall survival (i.e., the survival time following the moment when samples were taken), the stage and the mutation status of certain oncogenes or tumor suppressor genes, such as APC, KRAS and p53 [Shen et al. (2007) ]. These are summarized in Table 3 . Notice that this data set contains only one sample classified in stage I, which however is statistically significant to our data.
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Three types of tests were made, one on this whole data and two when data 5 To detect whether this sample is an outlier and if it may perturb our analyses, we performed Dixon's Q test on two sets containing the number and the values of all alterations, respectively. By a comparison we detected that this sample is not any less statistically relevant than the others [Verma & Quiroz-Ruiz (2006) ]. . For each of the three types of tests mentioned above, we obtained a number of 30 different orderings: for each of the 15 types of chromosome measures that we defined two orderings were obtained by using, in turns, the L 1 and Euclidean distances. CNAs were considered recurrent when present in more than 5% of samples (δ min = 5) and 10%, for cases (ii) and (iii).
# Stage Surv. Vogelgram
Results and discussion. The 90 orderings that we obtained are ranked according to the squared deviation distance from the ideal ordering, which is the one yielded by the decreasing rate of survival predicted (see the Appendix) [Reid et al. (2009)] .
In Figure 4 the box plots of the minimum distances, for all three types of tests (i), (ii) and (iii), both for the L 1 and Euclidean distances (a table containing all the distances can be found in the appendix in Figure 6 ). It can be observed that, while the distribution of the distance are similar, with median values in the range 0.4 − 0.45, the lowest distance, i.e. the best ordering, is obtained (a) when CRC driver genes and recurrent CNAs are considered, (b) when the average of the alteration values is considered and (c) when Euclidean distance is used to build the TSP instance (see the Table in Fig. 6 ). This clearly outlines the importance of combining biological knowledge with mathematical techniques to achieve significant results, as one might expect.
The ordering is plotted in Figure 4 where its correlation with the survival time is shown. Samples in the left half of the ordering indicatively belong to patients with higher survival times, samples in the right half have lower survival times. The average survival time of the rightmost half is 22 months, while of the left half is 49. The data set contains two samples without survival time that were marked by a black asterisk. The inconsistencies between the stage and survival time are marked by either a red or a blue asterisk, respectively indicating too high/too low survival time prediction. As mentioned above, the algorithm determines the order without determining its initial sample, therefore the solution is time-reversible and the starting sample is chosen according to the biological knowledge [Gupta & Bar-Joseph (2008) ]. All in all, we may observe that for the best ordering there are considerably more samples in stages III and IV in the right half (20 samples) than in the left one (13 samples). Also, the number of samples in stages I and II in the left half (9 samples) surpasses the one in the right half (2 samples). Thus, we can state that the order is, to a certain degree, also compatible with the histological stage. We also remark that the sample having stage I is positioned in the first place.
We tested different chromosomal measures: the best and second best orderings display rather similar distances (0.189 and 0.247), while the other 88 orderings have quite similar distances varying in the range 0.318-0.468. Still we can conclude that, generally, amplifications or deletions considered separately induce a better ordering when values, intensities and numbers are considered, and regardless of the distance metrics. There are a few cases in which all alterations yielded a better ordering. Differently, when averaged values and intensities of all alterations are considered, a better ordering is obtained, for both metrics. However, in a few cases the results separately obtained for deletions or amplifications are better. Finally, on average it seems that the two distance metrics yield quite similar orderings, the differences between them being very small. Therefore, by looking at the performance of the algorithm on synthetic data (Figure 2) , we can hypothesize that the overall level of noise in the data set might be either very small or very high.
Colorectal cancer -data set 2
We also tested the technique on a public CRC microarray dataset form the Gene Expression Omnibus (GEO) database (GSE11417) [Edgar et al. (2002) ]. Tumor samples and paired normal tissues were hybridized to Affymetrix Mapping 50K Xba 240 arrays [Kurashina et al. (2008) ]. CNAs for each sample were obtained between pairs of tumors and normal samples. Raw intensity CEL files of the SNP arrays were processed with CNAG program, as for the first dataset.
The original data set consisted of 94 samples, but due to the fact that one of Table 4 : Colorectal cancer -dataset 2. Clinical data of the CRC data samples from the second dataset.
them did not have any CNAs, we excluded it from this analysis. As in the case of the previous dataset, for each sample we are given the number of alterations, per chromosome. Still, as opposed to the first dataset, here only the information regarding the histological stages for each sample is provided (Table 4) . As the overall survival time is missing, to compute the best result, we used the available information, i.e. the stages. We assumed that in an ideal ordering the first samples should have the least advanced stage and that the stages increase in the ordering such that the samples categorized in stage 4 are the last ones. Thus, we computed the square deviation distance for an ordering by summing up the distances between the position of each sample in the obtained ordering and the interval where the same sample should be placed in, according to stage information.
Results and discussion. Similarly to the previous experiment, we obtained 30 different orderings. Using the SDD as described above, we evaluated each of these orderings. In Fig. 5 we show the box plots of the distances, whereas in the table in Fig. 7 in the Appendix all the distances are shown. In this case the best ordering in terms of this distance was obtained for the test taking into account (a) the CRC driver genes and recurrent CNAs, with (b) the chromosome measure values of alterations and (c) the L 1 distance. We therefore remark that, as seen previously, it is important to also look at biological information, in conjunction with mathematical methods. Figure 5 illustrates the best ordering, plotted against the histological stages. We notice that the number of samples having stages I and II is higher for the left half (28 samples) compared to the right one (20 samples). In addition, we observe the inverse tendency in what concerns the samples in stages III and IV: there are less in the left half (19 samples), compared to the right one (26 samples). Another interesting observation is that all the samples having stage IV are correctly placed in the second half. Also in this experiment all alterations proved to be more important than just deletions or amplifications. The only difference is that here the values of alterations lead to the best ordering, while before it was the average of these values. As respects the two used distances, we remark that the minimum SDDs are obtained for the L 1 distance, but we must mention that on average, the values of the SDDs obtained by using the L 1 distance are only slightly dissimilar from those recovered using the Euclidean distance (at most 5 · 10 −1 units).
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In this paper we have presented a particular solution for the temporal ordering reconstruction problem (TOR) as defined in Section 1; we have built our approach on a previously proposed solution [Gupta & Bar-Joseph (2008) ], by adapting it to chromosomal copy number alterations (CNAs) data and we tested it on two colorectal cancer (CRC) data set. To the best of our knowledge, our work is the first to adapt the TSP approach to the TOR problem, in conjunction with CNA data; other approaches using CNAs have been published, but in their respect, we have actually implemented a finer control over the genome regions where CNAs actually appear. In order to capture different features of the complex copy number alteration phenomenon and to detect the most relevant with respect to our objectives, we defined and used: (i) several chromosome-related measures, i.e., the intensity, the values and the number of the overall alterations, the deletions and the amplifications (and their corresponding averaged versions); (ii) distinct filters targeting significant portions of chromosomes to be considered in the analysis, i.e., recurrent CNAs and cancer driver genes-related CNAs; and (iii) different distance metrics, i.e., Euclidean distance and L 1 distance. The various combinations of these distinct criteria result in a large number of different optimal orderings, according to the specific measures, filters and metrics used.
With respect to the considered data sets, two sets of patients affected by CRC at different progression stages, the validation was achieved by using the quantitative (yet clearly partially arbitrary) measures of overall survival (or life expectancy) or the histological stages (where the overall survival was not available). The techniques based on the values (and average values) of alterations of both the recurrent and cancer-driver genes-related CNAs proved to outperform all the other techniques, pointing at a the dramatic influence that the chromosome-related alteration of some key genes has on the development of the disease (and on the related life expectancy).
Regarding the first CRC data set, we must remark that since it is somehow not completely coherent (i.e., some patients characterized by advanced stages of the CRC progression were labeled with long life expectancies and vice versa), the best ordering with respect to the overall survival cannot be optimal with respect to the histological classification as well. We believe that is most likely due, on the one hand, to the scarce number of samples in our data set and, on the other hand, to the "hidden factors" that lucidly influence the survival expectancy and that were not considered in the analysis (e.g., age, gender, etc.).
Nevertheless, this outcome does not discredit the validity, the efficiency and the general applicability of the methodology.
As for future development of the present work, the first problem that we will address in deeper detail will be the issue of noise, given the limited robustness of the method with respect to relatively noisy data, as one can see looking at Figure 2 . Secondly, we plan to extend the evaluation, by proposing new chromosome-related measures. The copy number alterations are characterized by several distinct features (e.g., segment length, number, type, position) while the measures we used are mostly univariate. Hence, extending the definitions of the several chromosome-related measures, in order to capture a wider range of characteristic properties, could lead to better and more accurate results. Last, but not least, we will investigate how combining the presented approach with classification algorithms influences the results: after the samples are classified, the algorithm could be applied in order to obtain a partial temporal ordering for each class and thus reconstruct the final ordering.
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A.1 Solving a TSP instance
The standard formulation of the TSP problem, requires a TSP-solver to retrieve, from a starting city, the shortest path visiting each city exactly once and then returning to the original city. The route is determined by a graphlike representation of the cities and the available routes. In graph theory this is equivalent to finding the Hamiltonian cycle with the least weight, given a complete weighted graph. Here cities are represented by the samples, and a distance matrix is used to define the distances between any two samples. Two types of metrics are used to determine an overall distance between two vector samples: the L 1 distance || · || 1 introduced in Section 2
with x, y ∈ R n . With n samples, given that each chromosomal measure and both the Euclidean or the L 1 distances are independent of n, building such a matrix has a time complexity of Θ(n 2 ). As shown in Section 2, the work that we used as a starting point for our methodology introduces theorems stating that the unique TSP path reconstructs the correct ordering with high probability, theorems that are proved for the L 1 distance [Gupta & Bar-Joseph (2008) ]. Still, the Euclidean distance is widely used to describe (dis)similarities between genetic data, therefore we chose to use it as well. We also aim at comparing the results obtained with each type of metric in order to decide whether one is more suitable than the other for CNA data.
As in both cases the obtained distance matrices are symmetric, the problem is reduced to a symmetric version of the TSP. Nonetheless, it is clear that in our case the first and the last samples in the ordering should be distant from each other (i.e., the distance between their representing vectors should be large), considered the underlying hypotheses on copy number alterations described in the previous sections. Consequently, we solve the Open TSP, which searches for the shortest route that visits each city exactly once, but without returning to the origin city. The equivalent problem in graph theory is to find the Hamiltonian path having the minimum weight in an undirected complete weighted graph.
We used the Concorde tool to approximate the TSP solution [Applegate et al. (2003) ]. This software for the symmetric TSP combines linear programming and cutting planes to solve the instance, and has been used to obtain the optimal solutions to the full set of 110 TSPLIB instances [Cook (2011) ]. The Concorde TSP Solver [Applegate et al. (2003) ] solves the classical TSP. Therefore, we convert our Open TSP into a classical one by specifying exactly the starting node for the path, and by adding a supplementary "fake" node with distance zero to the first node and very large distance in relation to all other nodes. Then, the solution returned by the Concorde TSP Solver will be the cycle beginning and ending with the "fake" node. As soon as this node is removed from the solution, we obtain a non-cyclic path, representing the temporal ordering. However, as we do not know a priori which sample should be the first in the ordering, we try all of them and in the end, we choose the ordering that has the minimum cost of the path (i.e., minimum sum of distances between samples).
The order of samples obtained by Concorde will be, with high probability, the correct temporal ordering reflecting cancer progression, retrieved by using CNA data.
A.2 Synthetic data
We hypothesize the existence of N life expectancy classes C i , i = 1, . . . , N , the first class C 1 denoting the highest life expectancy and C N the shortest one. We then create a set of M samples S m , m = 1, . . . , M belonging to each class. A sample is again a j-dimensional vector V Sm Ci in which every value represents the overall CNAs of a specific chromosome and j is the number of the considered chromosomes. Every (integer) value of each vector is generated with uniform probability with respect to disjoint value ranges for the distinct classes (e.g., , in the higher range. The assumption that a larger CNA magnitude implies a lower survival rate as a consequence of the more advanced disease progression, is therefore fulfilled. Notice that the range of values assigned to each class is arbitrary, and the goal is to design an "ideal" data set P in which the N · M samples are naturally clustered according to the N classes.
We introduce noise as a parameter p ∈ [0, 1] representing the probability that to a single entry in a sample is assigned a random value among all classes, with uniform probability. This introduces, in each sample, a number of "noisy" CNAs following a Binomial distribution B(j, p). Thus, we build from P a noisy data set P p . For instance, if p = 0.1 around the 10% CNAs are random and hence incompatible with the expected life expectancy for the sample class. Here we introduced a noise as a model of potential measurement errors and intrinsic biological variability.
We discretized p in [0, 0.5] and, for each of its values, we created 100 different synthetic data sets with 10 different life expectancy classes containing 100 distinct samples. Besides, we considered data sets with three distinct numbers of chromosomes, i.e. j = 15, 20, 25. As performance we measure the accuracy of the obtained temporal ordering, e, as the average number of samples correctly classified in each class, and we consider equivalently ordered samples within each class. By averaging ensembles of executions of our algorithm we measure the performance variation for increasing values of p.
A.3 Evaluating ordering against predicted survival
Given that a number of different orderings is obtained for each dataset, we need a way to rank them to obtain the optimal one. We use the survival time (or overall survival) following the moment in which the samples were taken, under the assumption that the amount of CNAs and the progression of the disease are correlated (which intuitively results in a overall shortening of the life expectancy). Therefore, we operate as follows. We compute the "ideal ordering" by sorting all the samples for decreasing life expectancy, and we pick as ideal the ordering which is more similar to such an ordering.
Similarity is measured as the squared deviation distance (sdd) among the sequences [Sevaux & Sorensen (2005) ]. For each sample, the difference between its actual and the expected position is computed. The sdd is the sum of the squared values of these differences, for all samples. Thus, for any two orderings π and π , the sdd is
where π(i) = π (j) = k, and i, j ∈ {1, . . . , n}. Here i, j are the positions of sample k in the two permutations and n is the number of samples. 
